Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials

Journal of the American College of Cardiology

Volumn 27, Issue 5, 1996, Pages 1214-1218

  Moser, Marvin ^a,c   Hebert, Patricia R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029960897     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00606-0     Document Type: Article

References (29)

1. Clawson BJ. The heart in essential hypertension. In: Bell ET, editor. Hypertension. Minneapolis: University of Minnesota Press, 1950:349.
2. Schroeder HA. Hypertensive Diseases. Philadelphia: Lea & Febiger, 1953: 223.
3. Yusef F, Thom T, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 1989;13 Suppl 1:1-74.
4. Hebert P, Moser M, Mayer J, Hennekens C. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-81.
5. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease, II. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335: 827-38.
6. Moser M, Gifford F. Why less severe degrees of hypertension should be treated. J Hypertens 1985;3:437-47.
7. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension; results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202:1028-34.
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52.
9. US Public Health Service Hospitals Cooperative Study Group (Smith W). Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res 1977;40 Suppl 1:98-105.
10. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-71.
11. Australian National Blood Pressure Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980;1:1261-7.
12. Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial: the Oslo study. Am J Med 1980;69:725-32.
13. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974;229:409-18.
14. MRC Working Party. Medical Research Council trial of treatment of mild hypertension: principal results. Br Med J 1985;291:97-104.
15. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
16. Wilhelmsen L, Berglund G, Elmfeldt D, et al. Beta blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987;5:561-72.
17. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-12.
18. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;1:1349-54.
19. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-64.
20. Coope J, Warrender TS. Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986;293:1145-51.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
22. Borhani NO, Blaufox MD, Oberman A, Polk BF. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 1986;29:55-62.
23. Moser M, Setaro J. Antihypertensive drug therapy and regression of left ventricular hypertrophy: a review with a focus on diuretics. Eur Heart J 1991;12:1034-9.
24. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. Am J Hypertens 1992;5:95-110.
25. Neaton JD, Grimm RH, Prineas RJ, et al, for the Treatment of Mild Hypertension Study Research Group. Treatment of mild hypertension study: final results. JAMA 1993;270:713-24.
26. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. Result of a Department of Veterans Affairs Cooperative Study. N Engl J Med 1993;328:914-21,
27. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med 1992;14:998-1008.
28. Wolff FW, Lindeman RD. Effects of treatment in hypertension: results of a controlled study. J Chron Dis 1966;19:227-40.
29. Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970;1:485.